 Emergent BioSolutions led a decline for biotech stocks on Wednesday as EBS stock tumbled on declining sales and a delayed contract. The post Why Emergent Bio Is Leading A Biotech Bloodbath With Xenon Pharma Trailing appeared first on Investors Business Daily. 